All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
All you need to know about VIPoma: review on the latest studies
Presse Med. 2023 Dec 16:104222. doi: 10.1016/j.lpm.2023.104222. Online ahead of print.ABSTRACTVasoactive intestinal peptide secreting tumor (VIPoma) is a rare mostly malignant neuroendocrine tumor that is characterized by watery diarrhea, hypokalemia and achlorhydria due to the nonregulated increased secretion of VIP. VIPomas ar diagnosed by the presence of the most common symptoms, laboratory analysis of blood and stool, radiological imaging and immunohistochemical findings. Primary treatment includes fluid replacement, electrolyte balance correction, pharmacological treatment with somatostatin analogs, surgical resection...
Source: Presse Medicale - December 18, 2023 Category: General Medicine Authors: Emija Nikola Karele Source Type: research
XBB and BQ.1, the two Omicron cousins dominating globally: Is it the time we should think again?
Presse Med. 2023 Dec 14:104220. doi: 10.1016/j.lpm.2023.104220. Online ahead of print.NO ABSTRACTPMID:38103589 | DOI:10.1016/j.lpm.2023.104220 (Source: Presse Medicale)
Source: Presse Medicale - December 16, 2023 Category: General Medicine Authors: Rubai Ahmed Sovan Samanta Jhimli Banerjee Sandeep Kumar Dash Source Type: research
XBB and BQ.1, the two Omicron cousins dominating globally: Is it the time we should think again?
Presse Med. 2023 Dec 14:104220. doi: 10.1016/j.lpm.2023.104220. Online ahead of print.NO ABSTRACTPMID:38103589 | DOI:10.1016/j.lpm.2023.104220 (Source: Presse Medicale)
Source: Presse Medicale - December 16, 2023 Category: General Medicine Authors: Rubai Ahmed Sovan Samanta Jhimli Banerjee Sandeep Kumar Dash Source Type: research
Chronic heart failure with reduced EF: a decade of major pharmacological innovations
CONCLUSION: The results of the clinical trials reviewed here represent major advances that will have a significant impact on quality of life, survival, rehospitalisation and, for certain treatments, a beneficial joint effect on commonly associated comorbidities such as diabetes and chronic renal failure.PMID:38072123 | DOI:10.1016/j.lpm.2023.104219 (Source: Presse Medicale)
Source: Presse Medicale - December 10, 2023 Category: General Medicine Authors: Jean-No ël Trochu Source Type: research
